Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-17-048535

Chief Executive Officer bought 1,695 shares at $6.00 ($10,170)

From the SEC's structured data for this filing

Trades in this filing

Cohen Yuval · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-08-11 Purchase : show line 1 in the form +1,695 $6.00 $10,170 57,775 D
Open-market purchases · 1,695 sh · avg $6.00 · $10,170
Loading xslF345X03/doc4.xml…